Plain-English translation of NCT05439902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a medication called can help women with multiple sclerosis who experience painful urination and difficulty emptying their bladder. Multiple sclerosis often affects bladder control, causing pain and urgency that significantly impacts quality of life. Researchers want to see if this medication can safely reduce these symptoms and improve how well the bladder works.
Many people with MS struggle with painful urination and bladder problems that current treatments don't adequately address. This medication is already used for similar bladder issues in other conditions, so researchers want to test whether it can safely and effectively help MS patients too.
You would take a daily pill—either the study medication or a placebo (inactive pill)—for a set period while the research team monitors your symptoms through questionnaires and bladder function tests. You'll have multiple visits to the clinic where doctors will assess your urinary symptoms, bladder emptying, and quality of life. The study helps determine whether this medication truly improves bladder symptoms in women with MS compared to placebo.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France